NEW YORK, July 21 (GenomeWeb News) - Rubicon Genomics will extract small amounts of DNA from archived serum samples for the Genome Institute of Singapore, the Ann Arbor, Mich.-based company said today.
Under the agreement, Rubicon will isolate and amplify genomic DNA from 5,000 serum samples from a hepatitis B vaccine trial using its technology, which enables researchers to purify DNA from as few as 10 cells.
GIS plans to use the DNA in an international study with researchers in